Delivery Order SPE2DB22D3501-SPE2DB24FWM46
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,594.00 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty medication. The award has an ultimate completion date of August 1, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $83,437.62. This is a firm fixed-price delivery order contract with a period of performance ending on February 28, 2024. The contract was awarded on February 27, 2024, with no set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.22 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML pharmaceutical product. The contract has a performance period through March 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,583,809 units of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML. The $31,188.00 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 27, 2024. The contract is not set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,020.80, is for the delivery of GONAL-F RFF REDI-JECT 900 unit 1.5ML medical products. It is a firm-fixed-price delivery order contract with a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $15,942.66 and has an ultimate completion date of September 10, 2021. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,097.52 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $6,930.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Gonal-F RFF Redi-Ject 900 unit 1.5ml, a pharmaceutical product, with a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,481.11 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a ceiling value of $47,359.24. The contract is a firm fixed-price delivery order with a completion date of June 16, 2025. This award is not designated as a set-aside contract, indicating open competition....